Evidence map›Paper›PMID 29982878›Full record

Observational studyPediatric nephrology (Berlin, Germany)2018

Recurrence of nephrotic syndrome following kidney transplantation is associated with initial native kidney biopsy findings.

Jonathan H Pelletier, Karan R Kumar, Rachel Engen, Adam Bensimhon, Jennifer D Varner, Michelle N Rheault, Tarak Srivastava, Caroline Straatmann, Cynthia Silva, T Keefe Davis and 17 more

Erratum issuedOpen access · greenAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Pediatric nephrology (Berlin, Germany), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 24 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 3 pooled it
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 3 syntheses or guidelines pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Pooled it
  4. KDOQI US Commentary on the KDIGO 2025 Clinical Practice Guideline for the Management of Nephrotic Syndrome in Children.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2026
    Review
  5. Personalized disease recurrence modeling using iPSC-derived podocytes in patients with idiopathic nephrotic syndrome.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2025
    Article
  6. Review
  7. Article
  8. What is circulating factor disease and how is it currently explained?Pediatric nephrology (Berlin, Germany) · 2023
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Adult survivors of idiopathic childhood onset nephrotic syndrome.Pediatric nephrology (Berlin, Germany) · 2021
    Article
  16. Article
  17. Article
  18. Individualizing Treatment of Steroid-Resistant Nephrotic Syndrome: Registries to the Fore.Clinical journal of the American Society of Nephrology : CJASN · 2020
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

27 authors at 15 institutions in 2 countries.

Jonathan H PelletierDepartment of Pediatrics, Divisions of Nephrology and Critical Care, Duke University Medical Center, Durham, NC, 27710, USA.
Karan R KumarDepartment of Pediatrics, Divisions of Nephrology and Critical Care, Duke University Medical Center, Durham, NC, 27710, USA.
Rachel EngenAnn & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois and Children's Hospital Seattle, Washington, USA.
Adam BensimhonDepartment of Pediatrics, Divisions of Nephrology and Critical Care, Duke University Medical Center, Durham, NC, 27710, USA.
Jennifer D VarnerDepartment of Pediatrics, Divisions of Nephrology and Critical Care, Duke University Medical Center, Durham, NC, 27710, USA.
Michelle N RheaultUniversity of Minnesota Masonic Children's Hospitals, Minneapolis, MN, USA.
Tarak SrivastavaChildren's Mercy Hospital, Kansas City, MO, USA.
Caroline StraatmannLouisiana State University Children's Hospital, New Orleans, Louisiana, USA.
Cynthia SilvaConnecticut Children's Medical Center, Hartford, CT, USA.
T Keefe DavisSt. Louis Children's Hospital, St Louis, MO, USA.
Scott E WenderferBaylor College of Medicine, Texas Children's Hospital, Houston, TX, USA.
Keisha GibsonNorth Carolina Children's Hospital, Chapel Hill, NC, USA.
David SelewskiC.S. Mott Children's Hospital, Ann Arbor, MI, USA.
John BarciaUniversity of Virginia Children's Hospital, Charlottesville, Virginia, USA.
Patricia WengMattel Children's Hospital University of California, California, Los Angeles, USA.
Christoph LichtThe Hospital for Sick Children, Toronto, ON, Canada.
Natasha JawaThe Hospital for Sick Children, Toronto, ON, Canada.
Mahmoud KallashNationwide Children's Hospital, Columbus, OH, USA.
John W ForemanDepartment of Pediatrics, Divisions of Nephrology and Critical Care, Duke University Medical Center, Durham, NC, 27710, USA.
Delbert R WigfallDepartment of Pediatrics, Divisions of Nephrology and Critical Care, Duke University Medical Center, Durham, NC, 27710, USA.
Annabelle N ChuaDepartment of Pediatrics, Divisions of Nephrology and Critical Care, Duke University Medical Center, Durham, NC, 27710, USA.
Eileen ChambersDepartment of Pediatrics, Divisions of Nephrology and Critical Care, Duke University Medical Center, Durham, NC, 27710, USA.
Christoph P HornikDepartment of Pediatrics, Divisions of Nephrology and Critical Care, Duke University Medical Center, Durham, NC, 27710, USA.
Eileen D BrewerBaylor College of Medicine, Texas Children's Hospital, Houston, TX, USA.
Shashi K NagarajDepartment of Pediatrics, Divisions of Nephrology and Critical Care, Duke University Medical Center, Durham, NC, 27710, USA.
Larry A GreenbaumEmory University and Children's Healthcare of Atlanta, Atlanta, GA, USA.
Rasheed A GbadegesinDepartment of Pediatrics, Divisions of Nephrology and Critical Care, Duke University Medical Center, Durham, NC, 27710, USA. rasheed.gbadegesin@duke.edu.ORCID 0000-0001-5641-6644
Duke Medical Center · USBaylor College of Medicine · USHospital for Sick Children · CAChildren's Mercy Hospital · USConnecticut Children's Medical Center · USC. S. Mott Children's Hospital · USDuke University · USEmory University · USLouisiana State University · USLurie Children's Hospital · USMattel Children's Hospital · USNationwide Children's Hospital · USSt. Louis Children's Hospital · USUniversity of Minnesota Children's Hospital · USUniversity of Virginia Children's Hospital · US

Funding

Duke Research Training Program for PediatriciansT32HD043029 · NICHD · DUKE UNIVERSITY · PI BENJAMIN, DANIEL K. · 2002 to 2017
$3.7M
Gene Discovery in Autosomal Dominant Focal Segmental GlomerulosclerosisR01DK094987 · NIDDK · DUKE UNIVERSITY · PI GBADEGESIN, RASHEED ADEBAYO · 2012 to 2016
$2.5M
Functional and Phenotypic Characterization of a New FSGS GeneR01DK098135 · NIDDK · DUKE UNIVERSITY · PI GBADEGESIN, RASHEED ADEBAYO · 2014 to 2018
$1.8M
Doris Duke Charitable Foundation CREMNICHD NIH HHS T32 HD043029NIDDK NIH HHS 5R01DK098135 and 5R01DK094987NIDDK NIH HHS R01 DK094987NIDDK NIH HHS R01 DK098135
6 · The paper itself

Abstract

BACKGROUND AND

objectivesSteroid-resistant nephrotic syndrome (SRNS) due to focal segmental glomerulosclerosis (FSGS) and minimal change disease (MCD) is a leading cause of end-stage kidney disease in children. Recurrence of primary disease following transplantation is a major cause of allograft loss. The clinical determinants of disease recurrence are not completely known. Our objectives were to determine risk factors for recurrence of FSGS/MCD following kidney transplantation and factors that predict response to immunosuppression following recurrence.

methodsMulticenter study of pediatric patients with kidney transplants performed for ESKD due to SRNS between 1/2006 and 12/2015. Demographics, clinical course, and biopsy data were collected. Patients with primary-SRNS (PSRNS) were defined as those initially resistant to corticosteroid therapy at diagnosis, and patients with late-SRNS (LSRNS) as those initially responsive to steroids who subsequently developed steroid resistance. We performed logistic regression to determine risk factors associated with nephrotic syndrome (NS) recurrence.

resultsWe analyzed 158 patients; 64 (41%) had recurrence of NS in their renal allograft. Disease recurrence occurred in 78% of patients with LSRNS compared to 39% of those with PSRNS. Patients with MCD on initial native kidney biopsy had a 76% recurrence rate compared with a 40% recurrence rate in those with FSGS. Multivariable analysis showed that MCD histology (OR; 95% CI 5.6; 1.3-23.7) compared to FSGS predicted disease recurrence.

conclusionsPediatric patients with MCD and LSRNS are at higher risk of disease recurrence following kidney transplantation. These findings may be useful for designing studies to test strategies for preventing recurrence.

Indexed as

AdolescentAdultBiopsyChildChild, PreschoolDrug ResistanceFemaleGlomerulosclerosis, Focal SegmentalGlucocorticoidsGraft RejectionHumansInfantInfant, NewbornKidneyKidney TransplantationMaleGlucocorticoidsFocal segmental glomerulosclerosisImmunosuppressionLipoidNephrosisNephrotic syndromeTransplantation

Identifiers

PMID29982878
PMCPMC6129203
OpenAlexW2826605175

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.